Global Alzheimers Platform Foundation ApplaudsFDA Authorization of the First Blood-Based Diagnostic Test for Assessing Alzheimers Disease
WASHINGTON, May 20, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation®…
BioAegis Therapeutics Announces Site Activation and Patient Recruitment Underway in 13 Countries in Phase 2b Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)
600-patient study to assess efficacy of rhu-pGSN, an immune system regulator that…
Draganfly and SafeLane Global Enter into Multi-Year Agreement with Draganfly as the Preferred Global Provider of Landmine Mapping Drones and Aerial Survey Services
First Ukraine Landmine Aerial Survey Contract Underway Tampa, FL, April 10, 2025…
BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
– BRTX-100 is the first and only stem cell product candidate cleared…
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a…
Ibex Medical Analytics Receives First FDA 510(k) Clearance
FDA clearance affirms Ibex’s position as a global leader in AI-powered cancer…
InkSpace Imaging Receives FDA 510(k) Clearance for 1.5T 24-channel MR Coil for Siemens Healthineers
PLEASANTON, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- InkSpace Imaging, a leader…
Solid Biosciences Announces FDA IND Clearance for First-In-Industry Dual Route of Administration Gene Therapy to Treat Both Neurologic and Cardiac Manifestations of Friedreichs Ataxia
- SGT-212 is the only full-length frataxin replacement gene therapy candidate targeting…
AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market
New collagen-based dermal matrix designed for tissue generation, complementary to RECELL and…
Revolutionizing Heart Health: Frontier X Plus Gains FDA Clearance
NEW YORK, Nov. 13, 2024 /PRNewswire/ -- Fourth Frontier, a medical technology…
